how often should you take glp-1 Medications: Everything Need to Know When to Titrate Up Your

J.WaddenT

Horm Metab Res 2020;52:532-9.ArticlePubMed 62

As a result of this, protective or adverse effects cannot be fully excluded

Some patients find their optimal therapeutic dose is lower than the maximum licensed dose, and this is clinically acceptable if glycaemic targets are achieved

Am J Cardiovasc Drugs

For beneficiaries to be eligible under the BALANCE Model, providers must attest that they meet certain clinical criteria, including qualifying for a GLP-1 for a currently covered use (such as type 2 diabetes, cardiovascular disease risk reduction, or sleep apnea) or for use to treat obesity based on similar clinical criteria as applied in the Medicare GLP-1 Bridge (Figure 3)